Trial intelligence / Profile preview

Simvastatin for Uterine Leiomyoma in Infertile Patients

NCT03134157Phase 3Unknown

Sponsor
Royan Institute
Start
Aug 2016
Primary completion
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of simvastatin in uterine leiomyoma, sponsored by Royan Institute. Status: unknown.

02

Drugs

simvastatin
03

Conditions

uterine leiomyoma

Beyond the preview

Go deeper on NCT03134157.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03134157.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call